[What contribution can make artificial intelligence to urinary cytology?]

Ann Pathol. 2024 May;44(3):195-203. doi: 10.1016/j.annpat.2024.03.003. Epub 2024 Apr 12.
[Article in French]

Abstract

Urinary cytology using the Paris system is still the method of choice for screening high-grade urothelial carcinomas. However, the use of the objective criteria described in this terminology shows a lack of inter- and intra-observer reproducibility. Moreover, if its sensitivity is excellent on instrumented urine, it remains insufficient on voided urine samples. Urinary cytology appears to be an excellent model for the application of artificial intelligence to improve performance, since the objective criteria of the Paris system are defined at cellular level, and the resulting diagnostic approach is presented in a highly "algorithmic" way. Nevertheless, there is no commercially available morphological diagnostic aid, and very few predictive devices are still undergoing clinical validation. The analysis of different systems using artificial intelligence in urinary cytology rises clear prospects for mutual contributions.

Keywords: Artificial intelligence; Cytologie urinaire; Intelligence artificielle; Système de Paris; TPSRUC; Urinary cytology.

Publication types

  • Review
  • English Abstract

MeSH terms

  • Artificial Intelligence*
  • Carcinoma, Transitional Cell / diagnosis
  • Carcinoma, Transitional Cell / pathology
  • Carcinoma, Transitional Cell / urine
  • Cytodiagnosis / methods
  • Cytology
  • Humans
  • Sensitivity and Specificity
  • Urinalysis / methods
  • Urinary Bladder Neoplasms / diagnosis
  • Urinary Bladder Neoplasms / pathology
  • Urinary Bladder Neoplasms / urine
  • Urine / cytology
  • Urologic Neoplasms / diagnosis
  • Urologic Neoplasms / pathology
  • Urologic Neoplasms / urine